Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)-Reference-Cited by-同舟云学术

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Published:2014-11 Issue:17 Volume:50 Page:2983-2993
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bonnetain Franck,Bonsing Bert,Conroy Thierry,Dousseau Adelaide,Glimelius Bengt,Haustermans Karin,Lacaine François,Van Laethem Jean Luc,Aparicio Thomas,Aust Daniela,Bassi Claudio,Berger Virginie,Chamorey Emmanuel,Chibaudel Benoist,Dahan Laeticia,De Gramont Aimery,Delpero Jean Robert,Dervenis Christos,Ducreux Michel,Gal Jocelyn,Gerber Erich,Ghaneh Paula,Hammel Pascal,Hendlisz Alain,Jooste Valérie,Labianca Roberto,Latouche Aurelien,Lutz Manfred,Macarulla Teresa,Malka David,Mauer Muriel,Mitry Emmanuel,Neoptolemos John,Pessaux Patrick,Sauvanet Alain,Tabernero Josep,Taieb Julien,van Tienhoven Geertjan,Gourgou-Bourgade Sophie,Bellera Carine,Mathoulin-Pélissier Simone,Collette Laurence

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Survival end point reporting in randomised cancer clinical trials: a review of major journals;Mathoulin-Pelissier;J Clin Oncol,2008

2. Guidance for industry clinical trial end-points for the approval of cancer drugs and biologics, Food and Drugs Administration, Department of Health and Human Services, 2007.

3. Issues in using progression-free survival when evaluating oncology products;Fleming;J Clin Oncol,2009

4. The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer;Nout;Breast Cancer Res Treat,2008

5. End-points in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials;Punt;J Natl Cancer Inst,2007

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed;Nature Reviews Clinical Oncology;2023-10-12

2. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas;Updates in Surgery;2023-08-03

3. Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors;Annals of Surgical Oncology;2023-02-11

4. Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on the Outcomes of Patients With Metastatic Pancreatic Adenocarcinoma (MPA) During First-Line Treatment With FOLFIRINOX: A Single-Center Retrospective Analysis;Cancer Control;2023-01-02

5. Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms;European Radiology;2022-11-15